Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01337154
What this trial is testing

First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Stage IIIB Non-small Cell Lung Cancer With Pleural EffusionStage IV Non-small Cell Lung Cancer
CytRx 140
Not applicableUnknownNCT01493011
What this trial is testing

Chemotherapy Combined With Whole-body Hyperthermia to Treat Stage IIIB/IV Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IIIBToxicity Due to Chemotherapy
Xijing Hospital 120
Testing effectiveness (Phase 2)Study completedNCT03526900
What this trial is testing

Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis

Who this might be right for
Non-small Cell Lung Cancer Stage IV
Spanish Lung Cancer Group 40
Not applicableStudy completedNCT03959137
What this trial is testing

BEPACT- Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in Belgium

Who this might be right for
Stage IV Non-small Cell Lung Cancer
MSD Belgium BVBA 215
Large-scale testing (Phase 3)UnknownNCT02622607
What this trial is testing

Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer

Who this might be right for
Lung Cancer
Tang-Du Hospital 200
Large-scale testing (Phase 3)Study completedNCT02027428
What this trial is testing

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

Who this might be right for
Squamous Cell Carcinoma, Non-Small-Cell Lung
Celgene 427
Not applicableStudy completedNCT00900328
What this trial is testing

Study of Tumor Samples From Patients With Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 280
Not applicableStudy completedNCT01333007
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 423
Large-scale testing (Phase 3)Study completedNCT00347412
What this trial is testing

Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Cellectar Biosciences, Inc. 903
Testing effectiveness (Phase 2)Active Not RecruitingNCT04625647
What this trial is testing

Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Who this might be right for
Lung AdenocarcinomaLung Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell Carcinoma+3 more
SWOG Cancer Research Network 116
Testing effectiveness (Phase 2)WithdrawnNCT00469976
What this trial is testing

Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group
Post-approval studies (Phase 4)Study completedNCT02316327
What this trial is testing

Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Fundacion Clinic per a la Recerca Biomédica 19
Testing effectiveness (Phase 2)Ended earlyNCT02119650
What this trial is testing

Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Carcinoma)
Incyte Corporation 76
Testing effectiveness (Phase 2)Study completedNCT00407550
What this trial is testing

Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Mayo Clinic 19
Post-approval studies (Phase 4)Study completedNCT01848613
What this trial is testing

Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 120
Testing effectiveness (Phase 2)Study completedNCT01557959
What this trial is testing

Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+6 more
Wake Forest University Health Sciences 45
Testing effectiveness (Phase 2)Study completedNCT00003989
What this trial is testing

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

Who this might be right for
Lung CancerMelanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 50
Not applicableStudy completedNCT04640935
What this trial is testing

Paclitaxel in Combination With Bevacizumab in Patients With Stage IV NSCLC.

Who this might be right for
Non Small Cell Lung Cancer
Centre Hospitalier Annecy Genevois 320
Large-scale testing (Phase 3)UnknownNCT00112710
What this trial is testing

Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University Hospital Birmingham 1,350
Testing effectiveness (Phase 2)Study completedNCT01262820
What this trial is testing

Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab

Who this might be right for
Lung Cancer
UNC Lineberger Comprehensive Cancer Center 15
Next Page